Cuba will begin new clinical trials of a drug developed by a local laboratory to treat Alzheimer's disease, according to the local Health Ministry which confirmed that the nasally administered drug NeuroEpo has achieved promising results in the treatment of neurodigestive pathologies. Alzheimer's disease is one of the leading causes of death...